Effect of low-dose aspirin on reducing cardiovascular events and mortality in individuals with CKD stages 3–5: a meta-analysis of randomized controlled trials

Abstract Background Chronic kidney disease (CKD) is a global health concern and an independent risk factor for cardiovascular disease. Despite optimal treatments, mortality remains high among CKD patients. This meta-analysis aimed to assess the balance between the cardiovascular benefits and the ble...

Full description

Bibliographic Details

Published in:	BMC Cardiovascular Disorders
Main Authors:	Jingwen Lin, Xueqiong Cao, Wu Fu, Liu Yang, Wanxian Zeng, Na Li, Maobai Liu, Hongfu Cai
Format:	Article
Language:	English
Published:	BMC 2025-04-01
Subjects:	Aspirin Major adverse cardiovascular events Chronic kidney disease Mortality
Online Access:	https://doi.org/10.1186/s12872-024-04354-4